查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1438227

至 2030 年花生過敏治療市場預測：按治療類型、給藥途徑、最終用戶和地區進行的全球分析

Peanut Allergy Treatment Market Forecasts to 2030 - Global Analysis By Treatment Type (Epinephrine, Antihistamines & Corticosteroids, Immunotherapy & Other Treatment Types), By Route Of Administration (Oral & Injectable), End User & By Geography
出版日期: | 出版商: Stratistics Market Research Consulting | 英文 200+ Pages | 商品交期: 2-3個工作天內

價格

根據 Stratistics MRC 的數據，2023 年全球花生過敏治療市場規模為 5.161 億美元，預計到 2030 年將達到 11.698 億美元，預測期內複合年成長率為 12.4%。

花生過敏治療包括多種策略來控制和減輕因食用花生而引起的過敏反應。方法包括避免過敏原、腎上腺素緊急干預以及旨在使免疫系統脫敏的過敏原免疫療法。這些治療方法旨在提高患者的安全性，最大限度地減少過敏反應，並提高花生過敏患者的整體生活品質。

根據ITC的貿易地圖，2021年阿根廷出口了634,080噸花生，其次是印度，出口量為563,268噸。

花生過敏盛行率增加

隨著全世界被診斷出患有花生過敏的人數增加，對有效治療方法的需求也增加。這一趨勢正在推動創新治療方法的研究和開發，包括過敏原免疫療法、緊急干預措施和預防措施。此外，隨著製藥公司和醫療保健提供者滿足對先進且易於使用的治療方法的需求，以管理和降低與花生過敏相關的風險，不斷擴大的患者群體正在推動市場成長。

昂貴的治療費用

與過敏原免疫治療、緊急干預和持續醫療管理相關的成本增加了患者和醫療保健系統的經濟負擔。由於某些治療的保險範圍有限，成本障礙進一步加劇。這種高昂的財務障礙可能會阻止患者尋求或繼續治療，影響患者的依從性和整體治療結果。

提高知曉率和診斷率

提高醫療保健專業人員和公眾對花生過敏的認知將有助於及早發現和診斷。隨著意識的提高，更多的患者將尋求醫療救助，治療選擇也會增加。這種趨勢不僅可以透過及時介入來改善患者的治療效果，而且還推動了對有效花生過敏治療的需求。上市公司和醫療保健提供者可以利用這一機會，開發創新治療方法，促進教育舉措，並促進醫學界和公眾對花生過敏的更全面了解。

接觸專家和治療中心的機會受到限制

獲得專家和治療中心的機會有限是花生過敏治療市場的主要威脅。花生過敏的患者在尋求專業醫療保健專業人員和指定治療設施方面可能會遇到挑戰。這種限制可能會阻礙及時診斷、個人化治療計劃和過敏原免疫療法的實施。缺乏訓練有素的專家可能會導致患者照護方面的差距並影響干預措施的有效性。

COVID-19 的影響

COVID-19 大流行造成了包括過敏診斷和治療在內的醫療服務中斷，影響了花生過敏治療市場。醫療保健優先事項的關閉、限制和轉變延遲了患者護理、診斷和治療的開始。此外，疫情也影響了臨床試驗和研究活動，影響了花生過敏治療的整體情況。隨著局勢穩定，市場逐漸復甦，人們更加重視病人安全和創新治療方法。

免疫治療領域預計將成為預測期內最大的市場

預計免疫療法領域將在預測期內主導花生過敏治療市場。這一優點是由於擴大採用過敏原免疫療法，包括皮下和舌下方法，旨在使免疫系統對花生脫敏。免疫療法專注於解決花生過敏的根本原因並減少過敏反應，已成為首選治療選擇，有助於該類別市場佔有率的顯著成長。

預計注射劑領域在預測期內的複合年成長率最高。

在預測期內，花生過敏治療市場預計注射劑領域將出現良好成長。推動這一成長的是對注射治療的日益偏好，特別是在嚴重過敏反應的緊急管理中使用腎上腺素自動注射器。隨著人們越來越關注過敏緊急情況的快速有效干預，注射劑領域有望顯著成長，為患者和看護者提供方便有效的解決方案。

比最大的地區

由於其先進的醫療基礎設施、對花生過敏的認知不斷提高以及積極的法規環境，北美預計將主導花生過敏治療市場。該地區對免疫療法等創新治療方法的關注以及花生過敏的高盛行率也是其市場領先地位的因素。此外，醫療和研究機構之間的合作正在推動花生過敏治療的進步，使北美成為開發和市場開拓的主要地點。

複合年成長率最高的地區

在歐洲地區，由於花生過敏盛行率不斷上升、對醫療保健研究的重視以及治療方案的進步，花生過敏治療市場預計將快速成長。醫療保健專業人員和患者意識的提高，加上支持性的法律規範，正在推動創新花生過敏治療方法的採用。隨著研究和開發的加強，歐洲為花生過敏治療的進步做出了重大貢獻，推動了預測期內市場的顯著成長。

免費客製化服務

訂閱此報告的客戶可以存取以下免費自訂選項之一：

  • 公司簡介
    • 其他市場參與者的綜合分析（最多 3 家公司）
    • 主要企業SWOT分析（最多3家企業）
  • 區域分割
    • 根據客戶興趣對主要國家的市場估計、預測和複合年成長率（註：基於可行性檢查）
  • 競爭基準化分析
    • 根據產品系列、地理分佈和策略聯盟對主要企業基準化分析

目錄

第1章執行摘要

第2章 前言

  • 概述
  • 相關利益者
  • 調查範圍
  • 調查方法
    • 資料探勘
    • 資料分析
    • 資料檢驗
    • 研究途徑
  • 調查來源
    • 主要調查來源
    • 二次調查來源
    • 先決條件

第3章市場趨勢分析

  • 促進因素
  • 抑制因素
  • 機會
  • 威脅
  • 最終用戶分析
  • COVID-19 的影響

第4章波特五力分析

  • 供應商的議價能力
  • 買方議價能力
  • 替代品的威脅
  • 新進入者的威脅
  • 競爭對手之間存在敵對關係

第5章全球花生過敏治療市場：依治療類型

  • 腎上腺素
  • 抗組織胺和皮質類固醇
  • 免疫療法
  • 其他治療類型

第6章全球花生過敏治療市場：依給藥途徑

  • 口服
  • 可注射的

第7章全球花生過敏治療市場：依最終用戶分類

  • 醫院
  • 診所
  • 門診手術中心
  • 家庭護理設置

第8章全球花生過敏治療市場：按地區

  • 北美洲
    • 美國
    • 加拿大
    • 墨西哥
  • 歐洲
    • 德國
    • 英國
    • 義大利
    • 法國
    • 西班牙
    • 其他歐洲國家
  • 亞太地區
    • 日本
    • 中國
    • 印度
    • 澳洲
    • 紐西蘭
    • 韓國
    • 其他亞太地區
  • 南美洲
    • 阿根廷
    • 巴西
    • 智利
    • 南美洲其他地區
  • 中東和非洲
    • 沙烏地阿拉伯
    • 阿拉伯聯合大公國
    • 卡達
    • 南非
    • 其他中東和非洲

第9章 主要進展

  • 合約、夥伴關係、協作和合資企業
  • 收購和合併
  • 新產品發布
  • 業務擴展
  • 其他關鍵策略

第10章 公司簡介

  • Aimmune Therapeutics
  • ALK-Abello A/S
  • Alladapt Immunotherapeutics, Inc
  • AnaptysBio, Inc.
  • DBV Technologies SA
  • GlaxoSmithKline plc
  • HAL Allergy Group
  • Merck & Co., Inc.
  • Mylan NV
  • Novartis AG
  • Pfizer Inc.
  • Prota Therapeutics
  • Regeneron Pharmaceuticals
  • Sanofi
  • Stallergenes Greer
Product Code: SMRC25196

According to Stratistics MRC, the Global Peanut Allergy Treatment Market is accounted for $516.1 million in 2023 and is expected to reach $1169.8 million by 2030 growing at a CAGR of 12.4% during the forecast period. Peanut allergy treatment involves various strategies to manage and alleviate allergic reactions triggered by the consumption of peanuts. Approaches include allergen avoidance, emergency interventions with epinephrine, and allergen immunotherapy, aimed at desensitizing the immune system. These treatments aim to enhance patient safety, minimize allergic responses, and improve the overall quality of life for individuals with peanut allergies.

According to the ITC trade map, in 2021, Argentina exported 634,080 metric ton of peanuts, followed by India with 563,268 metric ton in second place.

Market Dynamics:

Driver:

Increasing prevalence of peanut allergy

With a rising number of individuals diagnosed with peanut allergies globally, there is a growing need for effective treatment options. This trend propels research and development efforts towards innovative therapies, including allergen immunotherapy, emergency interventions, and preventive measures. Moreover, the expanding patient pool fosters market growth as pharmaceutical companies and healthcare providers address the demand for advanced and accessible treatments to manage and mitigate the risks associated with peanut allergies.

Restraint:

High cost of treatment

Expenses associated with allergen immunotherapy, emergency interventions, and ongoing medical management contribute to the financial burden on patients and healthcare systems. Limited insurance coverage for certain treatments further exacerbates the cost barrier. This high financial threshold may deter some individuals from seeking or continuing treatment, impacting overall patient adherence and outcomes.

Opportunity:

Rising awareness and diagnosis rates

Increased awareness among healthcare professionals and the general public about peanut allergies leads to early detection and diagnosis. As awareness grows, more individuals seek medical attention, creating a larger patient pool for treatment options. This trend not only improves patient outcomes by enabling timely interventions but also drives the demand for effective peanut allergy treatments. Pharmaceutical companies and healthcare providers can capitalize on this opportunity by developing innovative treatments, fostering education initiatives, and contributing to a more comprehensive understanding of peanut allergies in both medical communities and the public.

Threat:

Limited access to specialists and treatment centers

Limited access to specialists and treatment centers poses a significant threat to the peanut allergy treatment market. Patients facing peanut allergies may encounter challenges in accessing specialized healthcare professionals and designated treatment facilities. This limitation can hinder timely diagnosis, personalized treatment plans, and the administration of allergen immunotherapy. The scarcity of trained specialists may contribute to gaps in patient care, impacting the effectiveness of interventions.

Covid-19 Impact:

The COVID-19 pandemic has impacted the peanut allergy treatment market by causing disruptions in healthcare services, including allergy diagnostics and treatments. Lockdowns, restrictions, and shifts in healthcare priorities led to delays in patient care, diagnosis, and treatment initiation. Additionally, the pandemic affected clinical trials and research activities, influencing the overall landscape of peanut allergy treatment. As the situation stabilizes, the market is gradually recovering, with an increased emphasis on patient safety and innovative treatment approaches.

The Immunotherapies segment is expected to be the largest during the forecast period

The immunotherapies segment is anticipated to be the largest in the peanut allergy treatment market during the forecast period. This dominance is attributed to the increasing adoption of allergen immunotherapy, including subcutaneous and sublingual approaches, aimed at desensitizing the immune system to peanuts. With a focus on addressing the root cause of peanut allergies and reducing allergic reactions, immunotherapies emerge as a preferred treatment option, contributing to the segment's substantial market share growth.

The injectable segment is expected to have the highest CAGR during the forecast period

The injectable segment is projected to experience lucrative growth in the peanut allergy treatment market during the forecast period. This growth is driven by the increasing preference for injectable forms of treatment, particularly the use of epinephrine auto-injectors for emergency management of severe allergic reactions. With a heightened focus on rapid and efficient intervention during allergic emergencies, the injectable segment is poised for substantial growth, offering a convenient and effective solution for patients and caregivers.

Region with largest share:

North America is poised to dominate the peanut allergy treatment market due to advanced healthcare infrastructure, heightened awareness of peanut allergies, and a proactive regulatory environment. The region's focus on innovative therapies, including immunotherapies, and a higher prevalence of peanut allergies contribute to its market leadership. Additionally, collaborations between healthcare organizations and research institutions further drive advancements in peanut allergy treatment, positioning North America as a key hub for developments and market dominance.

Region with highest CAGR:

The European region foresees rapid growth in the peanut allergy treatment market due to the increasing prevalence of peanut allergies, a strong emphasis on healthcare research, and advancements in treatment options. Rising awareness among healthcare professionals and patients, coupled with supportive regulatory frameworks, propels the adoption of innovative peanut allergy therapies. As research and development efforts intensify, Europe emerges as a significant contributor to advancements in peanut allergy treatment, driving substantial market growth in the forecasted period.

Key players in the market

Some of the key players in Peanut Allergy Treatment Market include Aimmune Therapeutics, ALK-Abello A/S, Alladapt Immunotherapeutics, Inc, AnaptysBio, Inc., DBV Technologies SA, GlaxoSmithKline plc, HAL Allergy Group, Merck & Co., Inc., Mylan N.V., Novartis AG, Pfizer Inc., Prota Therapeutics, Regeneron Pharmaceuticals, Sanofi and Stallergenes Greer.

Key Developments:

In June 2023, Alladapt Immunotherapeutics, Inc. has unveiled topline results of Phase 1/2 Harmony study assessing effectiveness & safety of ADP101 for treating food allergies. Outcomes indicate dose-dependent, clinically significant responses, and a favorable safety profile in pediatric patients with single or multiple food allergies. These promising findings suggest ADP101's potential as a safe and effective treatment for children with common food allergies.

In May 2023, DBV Technologies has made an announcement that the results of its Phase 3 EPITOPE trial involving EPIT using Viaskin Peanut in children aged 1 to 3 years have been published in the New England Journal of Medicine. This publication underscores the potential of a new food allergy treatment option for this specific age group, offering hope for the management of food allergies in young children.

Treatment Types Covered:

  • Epinephrine
  • Antihistamines and Corticosteroids
  • Immunotherapy
  • Other Treatment Types

Route of Administrations Covered:

  • Oral
  • Injectable

End Users Covered:

  • Hospitals
  • Clinics
  • Ambulatory Surgical Centers
  • Homecare Settings

Regions Covered:

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • Germany
    • UK
    • Italy
    • France
    • Spain
    • Rest of Europe
  • Asia Pacific
    • Japan
    • China
    • India
    • Australia
    • New Zealand
    • South Korea
    • Rest of Asia Pacific
  • South America
    • Argentina
    • Brazil
    • Chile
    • Rest of South America
  • Middle East & Africa
    • Saudi Arabia
    • UAE
    • Qatar
    • South Africa
    • Rest of Middle East & Africa

What our report offers:

  • Market share assessments for the regional and country-level segments
  • Strategic recommendations for the new entrants
  • Covers Market data for the years 2021, 2022, 2023, 2026, and 2030
  • Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
  • Strategic recommendations in key business segments based on the market estimations
  • Competitive landscaping mapping the key common trends
  • Company profiling with detailed strategies, financials, and recent developments
  • Supply chain trends mapping the latest technological advancements

Free Customization Offerings:

All the customers of this report will be entitled to receive one of the following free customization options:

  • Company Profiling
    • Comprehensive profiling of additional market players (up to 3)
    • SWOT Analysis of key players (up to 3)
  • Regional Segmentation
    • Market estimations, Forecasts and CAGR of any prominent country as per the client's interest (Note: Depends on feasibility check)
  • Competitive Benchmarking
    • Benchmarking of key players based on product portfolio, geographical presence, and strategic alliances

Table of Contents

1 Executive Summary

2 Preface

  • 2.1 Abstract
  • 2.2 Stake Holders
  • 2.3 Research Scope
  • 2.4 Research Methodology
    • 2.4.1 Data Mining
    • 2.4.2 Data Analysis
    • 2.4.3 Data Validation
    • 2.4.4 Research Approach
  • 2.5 Research Sources
    • 2.5.1 Primary Research Sources
    • 2.5.2 Secondary Research Sources
    • 2.5.3 Assumptions

3 Market Trend Analysis

  • 3.1 Introduction
  • 3.2 Drivers
  • 3.3 Restraints
  • 3.4 Opportunities
  • 3.5 Threats
  • 3.6 End User Analysis
  • 3.7 Impact of Covid-19

4 Porters Five Force Analysis

  • 4.1 Bargaining power of suppliers
  • 4.2 Bargaining power of buyers
  • 4.3 Threat of substitutes
  • 4.4 Threat of new entrants
  • 4.5 Competitive rivalry

5 Global Peanut Allergy Treatment Market, By Treatment Type

  • 5.1 Introduction
  • 5.2 Epinephrine
  • 5.3 Antihistamines and Corticosteroids
  • 5.4 Immunotherapy
  • 5.5 Other Treatment Types

6 Global Peanut Allergy Treatment Market, By Route Of Administration

  • 6.1 Introduction
  • 6.2 Oral
  • 6.3 Injectable

7 Global Peanut Allergy Treatment Market, By End User

  • 7.1 Introduction
  • 7.2 Hospitals
  • 7.3 Clinics
  • 7.5 Ambulatory Surgical Centers
  • 7.6 Homecare Settings

8 Global Peanut Allergy Treatment Market, By Geography

  • 8.1 Introduction
  • 8.2 North America
    • 8.2.1 US
    • 8.2.2 Canada
    • 8.2.3 Mexico
  • 8.3 Europe
    • 8.3.1 Germany
    • 8.3.2 UK
    • 8.3.3 Italy
    • 8.3.4 France
    • 8.3.5 Spain
    • 8.3.6 Rest of Europe
  • 8.4 Asia Pacific
    • 8.4.1 Japan
    • 8.4.2 China
    • 8.4.3 India
    • 8.4.4 Australia
    • 8.4.5 New Zealand
    • 8.4.6 South Korea
    • 8.4.7 Rest of Asia Pacific
  • 8.5 South America
    • 8.5.1 Argentina
    • 8.5.2 Brazil
    • 8.5.3 Chile
    • 8.5.4 Rest of South America
  • 8.6 Middle East & Africa
    • 8.6.1 Saudi Arabia
    • 8.6.2 UAE
    • 8.6.3 Qatar
    • 8.6.4 South Africa
    • 8.6.5 Rest of Middle East & Africa

9 Key Developments

  • 9.1 Agreements, Partnerships, Collaborations and Joint Ventures
  • 9.2 Acquisitions & Mergers
  • 9.3 New Product Launch
  • 9.4 Expansions
  • 9.5 Other Key Strategies

10 Company Profiling

  • 10.1 Aimmune Therapeutics
  • 10.2 ALK-Abello A/S
  • 10.3 Alladapt Immunotherapeutics, Inc
  • 10.4 AnaptysBio, Inc.
  • 10.5 DBV Technologies SA
  • 10.6 GlaxoSmithKline plc
  • 10.7 HAL Allergy Group
  • 10.8 Merck & Co., Inc.
  • 10.9 Mylan N.V.
  • 10.10 Novartis AG
  • 10.11 Pfizer Inc.
  • 10.12 Prota Therapeutics
  • 10.13 Regeneron Pharmaceuticals
  • 10.14 Sanofi
  • 10.15 Stallergenes Greer

List of Tables

  • Table 1 Global Peanut Allergy Treatment Market Outlook, By Region (2021-2030) ($MN)
  • Table 2 Global Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 3 Global Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
  • Table 4 Global Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
  • Table 5 Global Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
  • Table 6 Global Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 7 Global Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
  • Table 8 Global Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
  • Table 9 Global Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
  • Table 10 Global Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 11 Global Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 12 Global Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 13 Global Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 14 Global Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
  • Table 15 North America Peanut Allergy Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 16 North America Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 17 North America Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
  • Table 18 North America Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
  • Table 19 North America Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
  • Table 20 North America Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 21 North America Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
  • Table 22 North America Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
  • Table 23 North America Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
  • Table 24 North America Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 25 North America Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 26 North America Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 27 North America Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 28 North America Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
  • Table 29 Europe Peanut Allergy Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 30 Europe Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 31 Europe Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
  • Table 32 Europe Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
  • Table 33 Europe Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
  • Table 34 Europe Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 35 Europe Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
  • Table 36 Europe Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
  • Table 37 Europe Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
  • Table 38 Europe Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 39 Europe Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 40 Europe Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 41 Europe Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 42 Europe Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
  • Table 43 Asia Pacific Peanut Allergy Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 44 Asia Pacific Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 45 Asia Pacific Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
  • Table 46 Asia Pacific Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
  • Table 47 Asia Pacific Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
  • Table 48 Asia Pacific Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 49 Asia Pacific Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
  • Table 50 Asia Pacific Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
  • Table 51 Asia Pacific Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
  • Table 52 Asia Pacific Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 53 Asia Pacific Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 54 Asia Pacific Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 55 Asia Pacific Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 56 Asia Pacific Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
  • Table 57 South America Peanut Allergy Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 58 South America Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 59 South America Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
  • Table 60 South America Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
  • Table 61 South America Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
  • Table 62 South America Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 63 South America Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
  • Table 64 South America Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
  • Table 65 South America Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
  • Table 66 South America Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 67 South America Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 68 South America Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 69 South America Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 70 South America Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)
  • Table 71 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Country (2021-2030) ($MN)
  • Table 72 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Treatment Type (2021-2030) ($MN)
  • Table 73 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Epinephrine (2021-2030) ($MN)
  • Table 74 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Antihistamines and Corticosteroids (2021-2030) ($MN)
  • Table 75 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Immunotherapy (2021-2030) ($MN)
  • Table 76 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Other Treatment Types (2021-2030) ($MN)
  • Table 77 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Route Of Administration (2021-2030) ($MN)
  • Table 78 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Oral (2021-2030) ($MN)
  • Table 79 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Injectable (2021-2030) ($MN)
  • Table 80 Middle East & Africa Peanut Allergy Treatment Market Outlook, By End User (2021-2030) ($MN)
  • Table 81 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Hospitals (2021-2030) ($MN)
  • Table 82 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Clinics (2021-2030) ($MN)
  • Table 83 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Ambulatory Surgical Centers (2021-2030) ($MN)
  • Table 84 Middle East & Africa Peanut Allergy Treatment Market Outlook, By Homecare Settings (2021-2030) ($MN)